Oncoustics AI and UHN Awarded OBIO® Early Adopter Health Network Grant to Trial Point of Care Liver Assessment Solutions in Clinic

OBIO NewsOntario Industry Updates
Written By Arsheen Kaur

Oncoustics, the world’s leader in AI-based analytics for processing raw ultrasound signal to do tissue

characterization, real-time diagnostics and non-invasive surveillance, recently announced that, in association with University Health Network (UHN), have been awarded an Early Adopter Health Network (EAHN™) Grant to trial the OnX Liver Assessment Solutions in UHN clinics. The grant, which is funded by the Ontario Bioscience Innovation Organization (OBIO®), enables Oncoustics and UHN to pilot and further develop the innovative technology.

Oncoustics is an OBIO® member, and past BDSP™, CAAP® and EAHN ™ participant.

Arsheen Kaur
Previous

Immugenia Obtains Pre-Seed Funding from adMare BioInnovations, ACET Capital, and Sherbrooke Innopole to Develop a Cancer Treatment Which Would Prevent Relapses
Next

Zucara Therapeutics' Positive Proof-of-Concept Data Secures Continued Funding Ahead of Planned Phase 2 Clinical Trial of ZT-01